Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 32171069

Venetoclax in combination with cytarabine with or without idarubicin in children with relapsed or refractory acute myeloid leukaemia: a phase 1, dose-escalation study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2020 Apr
First author
Karol SE

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2020 Apr;21(4):476-478. doi: 10.1016/S1470-2045(20)30136-4.
    note
    Source null
    related pmid
    32171068
    relationship
    Comment in

Authors and identifiers

  1. name
    Karol SE
    type
    Author
  2. name
    Alexander TB
    type
    Author
  3. name
    Budhraja A
    type
    Author
  4. name
    Pounds SB
    type
    Author
  5. name
    Canavera K
    type
    Author
  6. name
    Wang L
    type
    Author
  7. name
    Wolf J
    type
    Author
  8. name
    Klco JM
    type
    Author
  9. name
    Mead PE
    type
    Author
  10. name
    Das Gupta S
    type
    Author
  11. name
    Kim SY
    type
    Author
  12. name
    Salem AH
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Karol SE
    type
    Author
  2. name
    Alexander TB
    type
    Author
  3. name
    Budhraja A
    type
    Author
  4. name
    Pounds SB
    type
    Author
  5. name
    Canavera K
    type
    Author
  6. name
    Wang L
    type
    Author
  7. name
    Wolf J
    type
    Author
  8. name
    Klco JM
    type
    Author
  9. name
    Mead PE
    type
    Author
  10. name
    Das Gupta S
    type
    Author
  11. name
    Kim SY
    type
    Author
  12. name
    Salem AH
    type
    Author
bibliography ids
  1. nci-bib-bd1f2554cf8f3b3d2413d49d
book metadata
content sha256
4f99a84b475fff1aa347e0de483bd3c85824e711e8f7e1a265cb37f9d9f188d7
document type
citation
dois
  1. 10.1016/S1470-2045(20)30060-7
electronic publication date
display
2020 Mar 11
precision
day
year
2020
evidence scope
bibliographic_metadata_only
id
pubmed:32171069
immutable id
pubmed:32171069@4f99a84b475fff1aa347e0de483bd3c85824e711e8f7e1a265cb37f9d9f188d7
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
4
name
The Lancet. Oncology
nlm unique id
100957246
pages
551-560
volume
21
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2020 Apr;21(4):476-478. doi: 10.1016/S1470-2045(20)30136-4.
    note
    Source null
    related pmid
    32171068
    relationship
    Comment in
outcomes validated
false
pmid
32171069
provenance
batch id
4c5003fbb78890e89ae1
provider
NCBI PubMed ESummary
record sha256
a3ff1623d7e2621924aa68f8be13bdbf1a7f447d58d51f0c1a90626a344e2cd1
response sha256
890389583ce193a9c74e19c63678e418dad2088e82cb704b888b02fcc887d269
retrieved at
2026-09-09T23:47:48.270700+00:00
publication date
display
2020 Apr
precision
month
year
2020
publication types
  1. Clinical Trial, Phase I
  2. Journal Article
  3. Research Support, N.I.H., Extramural
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/32171069/
title
Venetoclax in combination with cytarabine with or without idarubicin in children with relapsed or refractory acute myeloid leukaemia: a phase 1, dose-escalation study.

Preserved source evidence · Not medical advice